CERO

CERo Therapeutics Holdings, Inc. (CERO) | Rumor.io

CERo Therapeutics Holdings

CERO

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)100%

Price to earnings ratio0

Market capitalization612.2K

Earnings per share9.04

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about CERO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% -0.02

Apr 7

CERO Therapeutics Holdings, Inc. is not mentioned in the provided social media posts.
Bitcoin is discussed in several posts, including warnings about its potential decline and the impact of quantum computing on its security.
A video is mentioned that explores the potential risks of quantum computing on the financial security of Bitcoin and other assets.

Generated by AI

Sentiment

Of the messages about CERO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100%	88.52% +2.39
Bearish	—	—	0%	11.48% -2.39

Bullish· Nov 4

$CERO has a low share float of 1.9 million shares, making it susceptible to significant price movements.
The company has a strong management team and is developing cancer drugs, with a potential upside of 47,000% from its current stock price.
$CERO has broken through resistance and is experiencing high volume, with momentum indicators suggesting a strong upward trend.

Bearish· Oct 30

$CERO's delisting could lead to a 95% drop in value.
The company's CEO has been criticized for handling the situation poorly.
$CERO's website being down is a bad sign, indicating potential company instability.

Generated by AI

Topics

Of the messages about CERO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	28.78%
Announcements	—	—	—	63.51%
Controversies	—	—	—	1.62%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	6.08%

Announcements· Sep 5

CERo Therapeutics Holdings, Inc. (CERO) received FDA Fast Track Designation for its lead investigational compound, CER-1236, for Acute Myeloid Leukemia (AML).
This designation adds to CER-1236's existing Orphan Drug Designation, providing additional regulatory and financial advantages for the company's cancer immunotherapy program.
CER-1236 is currently in a Phase 1/1b trial, and the company plans to raise funds to address a Nasdaq delisting challenge due to low stockholders' equity.

Technical Analysis· Jun 17

A short squeeze in $CERO may occur if the uptrend continues to hold, potentially leading to further price increases.
Technical indicators, such as a double bottom and a bullish pennant, suggest that $CERO may be heading towards a target of around $20.
A falling wedge on the one-minute graph indicates that $CERO may have a target of around $25.30, while a tight flag formation suggests a potential breakout.

Generated by AI

Community

Of the messages about CERO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	50%	37.29%
Newcomers	—	—	50%	62.71%

Jun 19

CERO Therapeutics Holdings, Inc. is being discussed for its price drop of 42.01% to $11.50, making it the daily biggest loser.
The company has announced a 1-for-20 reverse stock split, according to Yahoo Finance.
Some traders are comparing CERO's recent price action to that of another stock, BBLG, which has a small float and has recently undergone a reverse split.

Generated by AI

NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of CERo Therapeutics Holdings, Inc. CERo Therapeutics Holdings, Inc.’s securities were suspended on October 31, 2025 and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the ordinary shares, units, and rights of Bowen Acquisition Corp. Bowen Acquisition Corp’s securities were suspended on November 3, 2025 and have not trad

2mo agoYahoo Finance

Also Discussed

Investors talking about CERO also mention

#	Name	Attention
1	Banzai International Inc.BNZI	0%new
2	TMT Acquisition CorpTMTC	0%0
3	CDT Equity Inc.CDT	0%+0
4	ZCAR - Zoomcar Holdings, Inc.	——
5	VCI Global Ltd.VCIG	0%0
6	Webuy Global Ltd.WBUY	0%-0.02
7	FOXO - FOXO Technologies Inc.	——
8	Haoxi Health Technology Limited Class A Ordinary SharesHAO	0%0
9	Psyence Biomedical Ltd.PBM	0%new
10	NewGenIvf Group Limited Class A Ordinary SharesNIVF	0%0